Primecap Management CO Immunocore Holdings PLC Transaction History
Primecap Management CO
- $127 Billion
- Q4 2024
A detailed history of Primecap Management CO transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Primecap Management CO holds 2,668,550 shares of IMCR stock, worth $71.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,668,550
Previous 2,472,020
7.95%
Holding current value
$71.8 Million
Previous $77 Million
2.3%
% of portfolio
0.06%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding IMCR
# of Institutions
124Shares Held
35.9MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$180 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$131 Million2.34% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$58.9 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA1.56MShares$41.9 Million3.45% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$40.8 Million0.5% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.18B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...